Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Wang, East Brunswick
Hailin Wang, East Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100028929 | NUCLEIC ACID MOLECULES ENCODING GPR84 - The present invention is an isolated nucleic acid molecule encoding CD36, G | 02-04-2010 |
Hang-Yong Wang, East Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090099266 | Antifungal nail coat and method of use - Antifungal nail coat compositions containing an allylamine, an N,N-di(C | 04-16-2009 |
Lingyan Wang, East Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080200445 | Heterocyclic aspartyl protease inhibitors - Disclosed are compounds of the formula I | 08-21-2008 |
| 20090131411 | BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA - Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders. | 05-21-2009 |
| 20090258868 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 10-15-2009 |
| 20090306047 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 12-10-2009 |
| 20100292203 | HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS - Disclosed are compounds of the formula I | 11-18-2010 |
| 20100298284 | BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA - Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders. | 11-25-2010 |
Luquan Wang, East Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110081708 | Method of Sequence Optimization for Improved Recombinant Protein Expression using a Particle Swarm Optimization Algorithm - An improved gene sequence optimization method, the systematic optimization method, is described for boosting the recombinant expression of genes in bacteria, yeast, insect and mammalian cells. This general method takes into account of multiple, preferably most or all, of the parameters and factors affecting protein expression including codon usage, tRNA usage, GC-content, ribosome binding sequences, promoter, 5′-UTR, ORF and 3′-UTR sequences of the genes to improve and optimize the gene sequences to boost the protein expression of the genes in bacteria, yeast, insect and mammalian cells. In particular, the invention relates to a system and a method for sequence optimization for improved recombinant protein expression using a particle swarm optimization algorithm. The improved systematic optimization method can be incorporated into a software for more efficient optimization. | 04-07-2011 |
Maoliang Wang, East Brunswick, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090214472 | Interferon-beta polymer conjugates - Biologically-active, interferon-beta 1b-polymer conjugate compositions are disclosed. The polymer portion is preferably a polyalkylene oxide polymer having a molecular weight of at least about 12 kDa. Methods of making and using the same are also disclosed. | 08-27-2009 |
| 20100273236 | RECOMBINANT HOST FOR PRODUCING L-ASPARAGINASE II - The invention provides a recombinant | 10-28-2010 |